Skip to content
Toggle Navigation
ABOUT
About Us
Leadership & Board of Directors
Expanded Access
TECHNOLOGY
STERIWAVE
NEWS
INVESTORS
Share Price
Regulatory News
Email Alerts
Reports & Documentation
Corporate Governance
AIM Rule 26
Investor Contacts
CONTACT US
NEWS & ARTICLES
Web Master
2026-05-25T13:58:31-07:00
News
Steriwave ICU Study Outcomes Presented at CSRT2026
Search for:
Top Categories
Toggle Navigation
AMR
COVID-19
Infection Control
Steriwave
Research
Events
Steriwave receives regulatory approval in Mexico
December 12, 2022
Ondine receives funding for meat photodisinfection
December 5, 2022
Ondine reports full results from Phase 2 nasal photodisinfection trial
December 5, 2022
Ondine cuts COVID-19 rate in food processing plant
November 8, 2022
Ondine’s President and CTO receives IPA Lifetime Achievement Award
October 31, 2022
Ondine presents new efficacy data against MRSA
October 19, 2022
Steriwave™ cuts SSI risk by 47% at major hospital
October 19, 2022
The Ottawa Hospital pilots pre-surgical nasal disinfection
September 23, 2022
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
September 20, 2022
Previous
11
12
13
Next
Load More Posts
For Media Information
5654 & Company
+44 (0) 0791 7800 011
+44 (0) 0775 7697 357
ondinebiomedical@5654.co.uk
Page load link
Go to Top